Jefferson Capital, Inc. / DE
JCAP Nasdaq Short-Term Business Credit Institutions Financials FY2023βFY2025
Last close Β· Oct 23, 2026
$20.41
1.4%What Jefferson Capital, Inc. / DE does
No business description yet.
- Legal name
- Jefferson Capital, Inc. / DE
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 13, 2026
- Accession Β· CIK
- 0001104659-26-027199
0002046042
Revenue and margins
Jefferson Capital, Inc. / DE had $613M of revenue in fiscal 2025, up 41.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Jefferson Capital, Inc. / DE returned $63.5M to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Jefferson Capital, Inc. / DE can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $14.4M | $35.5M | $23.2M |
| Debt incl. finance leases | β | β | $1.8B |
| Net debt / EBITDA | β | β | 5.4x |
| Debt / equity | β | β | 3.7x |
| Interest coverage | 3.4x | 2.9x | 3.0x |
| Total assets | β | $1.7B | $2.1B |
| Total liabilities | β | $1.3B | $1.6B |
| Shareholders' equity | $304M | $383M | $476M |
| Net debt (β = net cash) | β | β | $1.7B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 3 | β / 5 |
| Accruals ratio | β | β2.4% | β4.3% |
| Altman Z'' | β | β | β |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $323M | $433M | $613M |
| Operating income | $164M | $220M | $316M |
| Interest expense | $48.1M | $77.2M | $106M |
| Pretax income | $121M | $138M | $218M |
| Income tax | $9.0M | $8.7M | $30.5M |
| Net income | $112M | $129M | $188M |
| Net income to common | $112M | $129M | $169M |
| Diluted EPS | β | β | $5.64 |
| Diluted shares | β | β | 0.03B |
| Cash flow | |||
| Cash from operations | $120M | $168M | $269M |
| Depreciation and amortization | $2.4M | $2.6M | $5.3M |
| Stock-based compensation | $1.0M | $0.0M | $17.2M |
| Acquisitions | $5.6M | $0.0M | $0.0M |
| Dividends paid | $30.6M | $36.0M | $63.5M |
| Dividends and buybacks | $30.6M | $36.0M | $63.5M |
| Balance sheet | |||
| Cash and short-term investments | $14.4M | $35.5M | $23.2M |
| Total debt | β | β | $1.8B |
| Property and equipment, net | β | $2.3M | $1.7M |
| Goodwill | $57.2M | $57.7M | $58.0M |
| Intangible assets | β | β | $6.5M |
| Total assets | β | $1.7B | $2.1B |
| Total liabilities | β | $1.3B | $1.6B |
| Shareholders' equity | $304M | $383M | $476M |
| Margins | |||
| Operating margin | 50.8% | 50.8% | 51.6% |
| EBITDA margin | 51.5% | 51.4% | 52.5% |
| Net margin | 34.5% | 29.7% | 30.6% |
| Returns | |||
| Return on capital | β | β | 12.3% |
| Return on equity | 36.7% | 37.6% | 43.8% |
| Return on assets | β | 7.8% | 10.0% |
| Return on tangible equity | 45.3% | 39.7% | 41.2% |
| Growth | |||
| Revenue growth | β | 34.1% | 41.5% |
| Net income growth | β | 15.6% | 45.8% |
| Financial health | |||
| Net debt / EBITDA | β | β | 5.4x |
| Debt / equity | β | β | 3.7x |
| Interest coverage | 3.4x | 2.9x | 3.0x |
| Capital allocation | |||
| Stock comp / revenue | 0.3% | 0.0% | 2.8% |
| Quality scores | |||
| Accruals ratio | β | β2.4% | β4.3% |
Source: SEC EDGAR XBRL filings (CIK 0002046042). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.